Vertex Pharmaceuticals, Inc. (VRTX)
443.05
-3.78
(-0.85%)
USD |
NASDAQ |
Jun 08, 14:25
Vertex Pharmaceuticals Shareholders Equity (Quarterly) : 19.36B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 31.42B |
| Biogen, Inc. | 18.65B |
| CRISPR Therapeutics AG | 1.815B |
| Halozyme Therapeutics, Inc. | 219.64M |
| Gilead Sciences, Inc. | 23.52B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.48B |
| Total Liabilities (Quarterly) | 7.122B |
| Debt to Equity Ratio | 0.1026 |
| Current Ratio | 3.023 |
| Net Debt Paydown Yield | -0.04% |